1887

Abstract

We have little information about the definite role of the thioredoxin antioxidant complex system during viral infection, particularly during human T-cell lymphotropic virus type 1 (HTLV-1) infection and the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) state. Therefore, we conducted comprehensive next-generation sequencing (NGS) analysis to determine Trx system expression changes in three categories of subjects: sero-negative HTLV-1 individuals, asymptomatic HTLV-1 people and HAM/TSP patients. We found that Trx capacity is reduced in the HAM/TSP state compared to healthy individuals, which indicates increasing inflammation and reduction of apoptosis, which might contribute to the progression of inflammation in the spinal cord, which in turn may develop into the HAM/TSP state.

Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000090
2020-01-14
2020-01-24
Loading full text...

Full text loading...

/deliver/fulltext/acmi/10.1099/acmi.0.000090/acmi000090.html?itemId=/content/journal/acmi/10.1099/acmi.0.000090&mimeType=html&fmt=ahah

References

  1. Rafatpanah H, Hosseini RF, Pourseyed SH. The impact of immune response on HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Iran J Basic Med Sci 2013;16:235
    [Google Scholar]
  2. Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H. Cytokine networks dysregulation during HTLV-1 infection and associated diseases. Viruses 2018;10:691 [CrossRef]
    [Google Scholar]
  3. Keikha M, Marcondes Fonseca LA, Casseb J. The relevance of HTLV-1-associated myelopathy/tropical spastic paraparesis in Iran: a review study. Rev Clin Med 2019;6:60–65
    [Google Scholar]
  4. Enose-Akahata Y, Vellucci A, Jacobson S. Role of HTLV-1 Tax and HBZ in the pathogenesis of HAM/TSP. Front Microbiol 2017;8:2563 [CrossRef]
    [Google Scholar]
  5. Fuzii HT, da Silva Dias GA, de Barros RJS, Falcão LFM, Quaresma JAS. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP). Life Sci 2014;104:9–14 [CrossRef]
    [Google Scholar]
  6. Shomali S, Avval FZ, Boostani R, Jarahi L, Youssefi M. Serum total antioxidant capacity status of HTLV‐1 infected patients. Acta Virol 2015;59(2:199–203
    [Google Scholar]
  7. Matthews JR, Wakasugi N, virelizier J-L, Yodoi J, Hay RT. Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62. Nucleic Acids Res 1992;20:3821–3830 [CrossRef]
    [Google Scholar]
  8. Aguiar CCT, Almeida AB, Araújo PVP, Abreu RN, Chaves EM et al. Oxidative stress and epilepsy: literature review. Oxid Med Cell Longev 2012;2012:1–12 [CrossRef]
    [Google Scholar]
  9. Yaghoubi N, Youssefi M, Hashemy SI, Rafatpanah H, Mashkani BA et al. Thioredoxin reductase gene expression and activity among human T‐cell lymphotropic virus type 1–infected patients. J Med Virol 2019;91:865–871
    [Google Scholar]
  10. Shomali S, Avval FZ, Boostani R, Jarahi L, Youssefi M. Serum total antioxidant capacity status of HTLV-1 infected patients. Acta Virol 2015;59:199–203 [CrossRef]
    [Google Scholar]
  11. Benhar M, Shytaj IL, Stamler JS, Savarino A. Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J Clin Invest 2016;126:1630–1639 [CrossRef]
    [Google Scholar]
  12. Yodoi J, Uchiyama T. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 1992;13:405–411 [CrossRef]
    [Google Scholar]
  13. Newman GW, Balcewicz-Sablinska MK, Guarnaccia JR, Remold HG, Silberstein DS. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med 1994;180:359–363 [CrossRef]
    [Google Scholar]
  14. Kalantari P, Narayan V, Natarajan SK, Muralidhar K, Gandhi UH et al. Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages. J Biol Chem 2008;283:33183–33190 [CrossRef]
    [Google Scholar]
  15. Mozhgani S-H, Zarei-Ghobadi M, Teymoori-Rad M, Mokhtari-Azad T, Mirzaie M et al. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: a systems virology study. J Cell Biochem 2018;119:3968–3979 [CrossRef]
    [Google Scholar]
  16. Mozhgani SH, Piran M, Zarei-Ghobadi M, Jafari M, Mokhtari-Azad T et al. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. bioRxiv 2019;754697:
    [Google Scholar]
  17. Kern JC, Kehrer JP. Free radicals and apoptosis: relationships with glutathione, thioredoxin and the Bcl family of proteins. Front Biosci 2005;10:1727–1738 [CrossRef]
    [Google Scholar]
  18. Funasaka Y, Ichihashi M. The effect of ultraviolet B induced adult T cell leukemia-derived Factor/Thioredoxin (ADF/TRX) on survival and growth of human melanocytes. Pigment Cell Res 1997;10:68–73 [CrossRef]
    [Google Scholar]
  19. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS et al. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004;23:5594–5606 [CrossRef]
    [Google Scholar]
  20. Enose-Akahata Y, Vellucci A, Jacobson S. Role of HTLV-1 Tax and HBZ in the pathogenesis of HAM/TSP. Front Microbiol 2017;8:2563 [CrossRef]
    [Google Scholar]
  21. Moens B, Decanine D, Menezes SM, Khouri R, Silva-Santos G et al. Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy. PLoS Negl Trop Dis 2012;6:e1729 [CrossRef]
    [Google Scholar]
  22. Karbalaei M, Keikha M. What is adult T-cell leukemia pathogenesis? system virology as a solution of this puzzle. Jundishapur J Chronic Dis Care 2019;8:1–2 [CrossRef]
    [Google Scholar]
  23. Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A et al. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol 1998;72:8852–8860
    [Google Scholar]
  24. Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J et al. Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax. AIDS Res Hum Retrov 2000;16:1669–1675 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000090
Loading
/content/journal/acmi/10.1099/acmi.0.000090
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error